Background and Purpose: We investigated the impact of the presence, burden, and location
of cerebral microbleeds (CMBs) on the risk of major adverse cerebrovascular and …

Background Cerebral microbleeds (CMBs) may have a differential impact on clinical
outcome in stroke patients with atrial fibrillation (AF) treated with different types of oral …

Objectives Cerebral microbleeds are associated with the risks of ischemic stroke and
intracranial hemorrhage, causing clinical dilemmas for antithrombotic treatment decisions …

Objectives: To assess the association between cerebral microbleeds (CMBs) and future
spontaneous intracerebral hemorrhage (ICH) risk in ischemic stroke patients with …

Background Nonvitamin K antagonist oral anticoagulants (NOACs) are considered superior,
or at least noninferior, to warfarin in preventing stroke or systemic embolism in patients with …

Background and purpose: Cerebral microbleeds (CMBs) could contribute to an increased
risk of intracerebral hemorrhage in patients with antithrombotic therapy (antiplatelets or …

Objectives The objective of this study was to investigate the safety of anticoagulation in
ischemic stroke (IS) patients with cerebral microbleeds (CMBs). Methods PubMed, Web of …

Background and purpose Cerebral microbleeds (CMB s) are associated with an increased
risk of intracerebral hemorrhage. The impact of oral anticoagulation (OAC) on CMB s is not …

Introduction Whether ischaemic stroke patients with atrial fibrillation (AF) and cerebral
microbleeds (CMBs) on MRI can be safely anticoagulated is a hotly debated topic. We …

Background Anticoagulant therapy increases the risk that cerebral microbleeds (CMBs)
progress to intracerebral hemorrhage, but whether the therapy increases risk of CMB …